New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Ivarmacitinib, a highly selective Janus kinase 1 inhibitor, tops placebo in managing signs and symptoms of active ankylosing ...

Fewer teenagers are consuming marijuana and alcohol than they were in the early 90s, but among those who reported prior-year ...

Referral to catheter ablation should not be delayed until the patient loses weight, say researchers for the PRAGUE-25 trial.

Bacille Calmette-Guérin revaccination shows no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents in a phase 2b study.

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

Daily medicines shortages are leaving patients at risk and pharmacists overwhelmed, a survey by Community Pharmacy England showed.

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...

Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care ...

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

Specifically, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) program requirements from two BCMA-directed CAR T-cell therapies for multiple myeloma — ciltacabtagene autoleucel ...